News

Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial
Soligenix Inc. (NASDAQ:SNGX) shares surged on Thursday as the company announced positive results from its Phase 2a ...
Asthma Treatment Market to Hit USD 36.36 Billion by 2032, Driven by Biologic Adoption and Technological Advancements in Inhalers | SNS Insider
The U.S. Asthma Treatment Market to Reach USD 10.81 Billion by 2032, Driven by Improved Inhalation Therapies, Precision Medicine, and Growing Awareness of Chronic Respiratory Conditions.Austin, July ...